Trial Outcomes & Findings for Safety and Efficacy of Periodontal Surgery in Supra-alveolar-type Defects With or Without Straumann® Emdogain (NCT NCT01614925)

NCT ID: NCT01614925

Last Updated: 2020-12-01

Results Overview

The change in Clinical Attachment Level (CAL) from Baseline to 12 Months. CAL measurements will be derived from the Probing Pocket Depth (PPD) and Gingival Margin (GM) measurements as follows: CAL = PPD - GM.

Recruitment status

TERMINATED

Target enrollment

35 participants

Primary outcome timeframe

12 Months

Results posted on

2020-12-01

Participant Flow

The recruitment was terminated prematurely.

Participant milestones

Participant milestones
Measure
Emdogain
Periodontal surgery with the additional use of Straumann® Emdogain Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
Periodontal Surgery
Periodontal surgery alone Periodontal surgery: Periodontal surgery alone
Overall Study
STARTED
18
17
Overall Study
COMPLETED
14
15
Overall Study
NOT COMPLETED
4
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Emdogain
Periodontal surgery with the additional use of Straumann® Emdogain Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
Periodontal Surgery
Periodontal surgery alone Periodontal surgery: Periodontal surgery alone
Overall Study
Withdrawal by Subject
1
0
Overall Study
Protocol Violation
3
2

Baseline Characteristics

Safety and Efficacy of Periodontal Surgery in Supra-alveolar-type Defects With or Without Straumann® Emdogain

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Emdogain
n=18 Participants
Periodontal surgery with the additional use of Straumann® Emdogain Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
Periodontal Surgery
n=17 Participants
Periodontal surgery alone Periodontal surgery: Periodontal surgery alone
Total
n=35 Participants
Total of all reporting groups
Age, Continuous
50.3 years
STANDARD_DEVIATION 14.0 • n=5 Participants
53.9 years
STANDARD_DEVIATION 13.2 • n=7 Participants
52.4 years
STANDARD_DEVIATION 13.2 • n=5 Participants
Sex: Female, Male
Female
8 Participants
n=5 Participants
14 Participants
n=7 Participants
22 Participants
n=5 Participants
Sex: Female, Male
Male
10 Participants
n=5 Participants
3 Participants
n=7 Participants
13 Participants
n=5 Participants
Region of Enrollment
United States
5 participants
n=5 Participants
7 participants
n=7 Participants
12 participants
n=5 Participants
Region of Enrollment
Switzerland
3 participants
n=5 Participants
3 participants
n=7 Participants
6 participants
n=5 Participants
Region of Enrollment
Germany
10 participants
n=5 Participants
7 participants
n=7 Participants
17 participants
n=5 Participants

PRIMARY outcome

Timeframe: 12 Months

The change in Clinical Attachment Level (CAL) from Baseline to 12 Months. CAL measurements will be derived from the Probing Pocket Depth (PPD) and Gingival Margin (GM) measurements as follows: CAL = PPD - GM.

Outcome measures

Outcome measures
Measure
Emdogain
n=14 Participants
Periodontal surgery with the additional use of Straumann® Emdogain Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
Periodontal Surgery
n=15 Participants
Periodontal surgery alone Periodontal surgery: Periodontal surgery alone
Clinical Attachment Level
-2.91 mm
Standard Deviation 1.3
-2.08 mm
Standard Deviation 1.32

SECONDARY outcome

Timeframe: 12 months after baseline

GM was measured by recording the distance from the Cemento-Enamel Junction (CEJ) to the margin of the gingiva at 6 sites (mesio-vestibular, mid-vestibular, disto-vestibular, mesio-oral, mid-oral, disto-oral) on the study teeth. Negative value for GM indicates gingival recession. A positive value for the GM indicates the gingiva was covering the CEJ.

Outcome measures

Outcome measures
Measure
Emdogain
n=14 Participants
Periodontal surgery with the additional use of Straumann® Emdogain Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
Periodontal Surgery
n=15 Participants
Periodontal surgery alone Periodontal surgery: Periodontal surgery alone
Change in Gingival Margin (GM) From Baseline to 12 Months
-0.36 mm
Standard Deviation 0.84
-0.27 mm
Standard Deviation 1.53

SECONDARY outcome

Timeframe: 12 months after baseline

PPD was measured before the area is anaesthetized by recording the distance from the gingival margin to the bottom of the probable pocket at 6 sites (mesio-vestibular, mid-vestibular, disto-vestibular, mesiooral, mid-oral, and disto-oral) on the study teeth.Negative value for PPD indicates reduction of pocket depth.

Outcome measures

Outcome measures
Measure
Emdogain
n=14 Participants
Periodontal surgery with the additional use of Straumann® Emdogain Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
Periodontal Surgery
n=15 Participants
Periodontal surgery alone Periodontal surgery: Periodontal surgery alone
Change in Probing Pocket Depth (PPD) From Baseline to 12 Months
-2.93 mm
Standard Deviation 1.44
-2.47 mm
Standard Deviation 1.12

SECONDARY outcome

Timeframe: 4 weeks after baseline

Postoperative wound healing was assessed by the EHI according to Wachtel et al. \[2003\] by visual assessment: 1. complete flap closure - no fibrin line in the interproximal area 2. complete flap closure - fine fibrin line in the interproximal area 3. complete flap closure - fibrin clot in the interproximal area 4. incomplete flap closure - partial necrosis of the interproximal tissue 5. incomplete flap closure - complete necrosis of the interproximal tissue The outcome measure was the percentage of EHI category 1 (complete flap closure - no fibrin line in the interproximal area)

Outcome measures

Outcome measures
Measure
Emdogain
n=14 Participants
Periodontal surgery with the additional use of Straumann® Emdogain Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
Periodontal Surgery
n=15 Participants
Periodontal surgery alone Periodontal surgery: Periodontal surgery alone
Early Wound Healing Index (EHI) Assessment at 4 Weeks After Baseline
93 percentage of EHI category 1
100 percentage of EHI category 1

SECONDARY outcome

Timeframe: 4 weeks after baseline

Visual Analog Scale (VAS) for post-surgical pain, minimum value=0, maximum value=10, higher score means worse outcome

Outcome measures

Outcome measures
Measure
Emdogain
n=14 Participants
Periodontal surgery with the additional use of Straumann® Emdogain Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
Periodontal Surgery
n=15 Participants
Periodontal surgery alone Periodontal surgery: Periodontal surgery alone
Comparison of Post-surgical Pain at 4 Weeks After Baseline
3.21 score on a scale
Standard Deviation 9.39
3.47 score on a scale
Standard Deviation 7.77

SECONDARY outcome

Timeframe: 12 months after baseline

The presence of BoP was recorded as a binary response on 6 sites (mesio-vestibular, midvestibular, disto-vestibular, mesio-oral, mid-oral, and disto-oral) on the study teeth. The percentage of positive events per total probing sites was calculated for each group. The outcome measure was the change between baseline and 12 months. Negative values indicate a decrease in BoP.

Outcome measures

Outcome measures
Measure
Emdogain
n=14 Participants
Periodontal surgery with the additional use of Straumann® Emdogain Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
Periodontal Surgery
n=15 Participants
Periodontal surgery alone Periodontal surgery: Periodontal surgery alone
Change in Bleeding on Probing (BoP) From Baseline to 12 Months
-36 percentage of BoP change
-13 percentage of BoP change

SECONDARY outcome

Timeframe: 12 months after baseline

RDH was examined by physical testing using cold air as a stimulus. The percentage of positive events per total testing sites was calculated for each group. The outcome measure was the change between baseline and 12 months. Negative values indicate a decrease in RDH.

Outcome measures

Outcome measures
Measure
Emdogain
n=14 Participants
Periodontal surgery with the additional use of Straumann® Emdogain Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
Periodontal Surgery
n=15 Participants
Periodontal surgery alone Periodontal surgery: Periodontal surgery alone
Change in Root Dentin Hypersensitivity (RDH) From Baseline to 12 Months
-21.4 percentage of RDH change
-26.7 percentage of RDH change

SECONDARY outcome

Timeframe: 12 months after baseline

The PI was recorded according to O'Leary et al. \[1972\] as a binary response at the mesial, distal, facial and lingual surfaces on the study teeth. The percentage of positive events per total sites was calculated for each group. The outcome measure was the change between baseline and 12 months. Negative values indicate a decrease in PI.

Outcome measures

Outcome measures
Measure
Emdogain
n=14 Participants
Periodontal surgery with the additional use of Straumann® Emdogain Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
Periodontal Surgery
n=15 Participants
Periodontal surgery alone Periodontal surgery: Periodontal surgery alone
Change in Plaque Index (PI) From Baseline to 12 Months
14.7 percentage of PI change
13.4 percentage of PI change

Adverse Events

Emdogain

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Periodontal Surgery

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Emdogain
n=18 participants at risk
Periodontal surgery with the additional use of Straumann® Emdogain Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
Periodontal Surgery
n=17 participants at risk
Periodontal surgery alone Periodontal surgery: Periodontal surgery alone
General disorders
Tooth hypersensitivity
0.00%
0/18 • 1 year
5.9%
1/17 • Number of events 1 • 1 year
General disorders
Aphthous ulcer
5.6%
1/18 • Number of events 1 • 1 year
0.00%
0/17 • 1 year

Additional Information

Michel Mallaun

Straumann

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place